Astronomer HR chief Kristin Cabot resigns following Coldplay 'kiss-cam' incident
"Kristin Cabot is no longer with Astronomer, she has resigned," a company spokesperson wrote in an email to CNBC Thursday. Cabot was the company's chief people officer.
Cabot and Byron, who is married with children, were shown in an intimate moment on the 'kiss cam' at a recent Coldplay show in Boston, and immediately hid when they saw their faces on the big screen. Lead singer Chris Martin said, "Either they're having an affair or they're just very shy." An attendee's video of the incident went viral.
Byron resigned from the company on Saturday. Both Cabot and Byron have been removed the company's leadership team webpage.
Pete DeJoy, Astronomer's interim CEO, wrote in a post earlier this week that recent and unexpected national attention has turned the company into "a household name."
In May, the New York-based company, which commercializes open source software, announced a $93 million investment round led by Bain Ventures and other investors, including Salesforce Ventures.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
Michelle Obama Breaks Down Her Favorite Bravo Shows: 'I Watch It All'
The former first lady said she finds reality television "fascinating"NEED TO KNOW The Wednesday, July 30, edition of the IMO with Michelle Obama & Craig Robinson podcast had Bowen Yang and Matt Rogers as guests During the episode, Obama discussed her love of reality television The former first lady has a particular interest in Bravo programmingMichelle Obama likes keeping things real, especially when it comes to what she watches on television. The former first lady candidly opened up about her love for Bravo programming on the Wednesday, July 30, edition of the IMO with Michelle Obama & Craig Robinson podcast, during which she had Las Culturistas hosts Bowen Yang and Matt Rogers as guests. According to Obama, "culture is king" and she likes to "educate" her brother Robinson and her husband Barack Obama about it. "The truth is that they razz me about my love of reality TV and the Real Housewives. I watch it all — all of it," she said, noting that she has a particular interest in the "New York gen babies." "I watched the first two episodes, and I'm just like, 'Oh, they're starting the babies off early,' " she said, referring to Next Gen NYC, which features the children of Bravo stars, as well as a group of newcomers. Rogers responded that "They're really like the princes and princesses of Bravo, now seeing if they're worth their salt when the camera's fixed on them," to which Obama said, "Right." After Yang said that it can be "really tricky to watch," Obama agreed, saying, "It is, but it's juice. It's tea." The PEOPLE Puzzler crossword is here! How quickly can you solve it? Play now! She proceeded by explaining why reality television is a "sociological study," and the "same thing" as sports. 'There's drama in sports. If I listen to ESPN for an hour, it's like watching The Real Housewives of Atlanta. You know? It's the same drama, and they're yelling at each other, and they don't get along," she said. "I mean, Stephen A. Smith, he's just like every other talk show host," continued Obama. 'I'm like, 'What's the difference?' It's just sociological drama. The fact that people over seasons of working together still can't get along, they still have the same arguments — and it's not just women, but this happens in sports, too." Obama admitted that she finds it fascinating, adding, " 'Why do you keep going to dinner together? It never ends well. And don't ever vacation with her, ever again, ever. And why can't we figure out this room thing?' "Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. Previous episodes of Next Gen NYC and The Real Housewives of Atlanta can be streamed on Peacock. Read the original article on People
Forbes
10 minutes ago
- Forbes
Sell HIMS Stock Ahead of Its Earnings?
Hims & Hers Health (NYSE:HIMS) is set to announce its earnings on Monday, August 4, 2025. Historically, HIMS stock has reacted unfavorably to earnings announcements. Since 2021, the stock has recorded a negative one-day return in 53% of instances after results. The median one-day decline has amounted to -5.8%, with a maximum one-day decrease of -22.3%. For traders focused on events, grasping these historical trends can be beneficial. While the actual results compared to consensus and expectations will be vital, there are two main strategies to contemplate: Analysts expect HIMS to report earnings of $0.23 per share on revenues of $552 million. This would mark substantial growth compared to the same quarter last year, which recorded earnings of $0.16 per share on revenues of $315 million. A possible positive factor for Hims & Hers' sales growth momentum is the reported underperformance of Novo Nordisk's weight loss medication in the U.S. due to the presence of compounded versions. Regarding fundamentals, HIMS has a market capitalization of $15 billion. Over the past twelve months, the company generated $1.8 billion in revenue and was operationally profitable, reporting $110 million in operating profits and a net income of $164 million. However, if you're looking for upside with less volatility than individual stocks, the Trefis High Quality portfolio offers an alternative — it has outperformed the S&P 500 and achieved returns exceeding 91% since its inception. Additionally, see – Is There More Upside For MSFT Stock? Review earnings reaction history of all stocks HIMS Stock Historical Likelihood of Positive Post-Earnings Return Here are some insights on one-day (1D) post-earnings returns: Additional information regarding the observed 5-Day (5D) and 21-Day (21D) returns post earnings is summarized along with the statistics in the table below. HIMS Stock Correlation Between 1D, 5D, and 21D Historical Returns A comparatively lower-risk strategy (though not effective if the correlation is weak) is to understand the relationship between short-term and medium-term returns post earnings, identify a pair that has the highest correlation, and perform the corresponding trade. For instance, if 1D and 5D exhibit the highest correlation, a trader can take a "long" position for the next 5 days if the 1D post-earnings return is positive. Here is some correlation information based on a 5-year and 3-year (more recent) timeframe. Note that the correlation 1D_5D denotes the relationship between 1D post-earnings returns and subsequent 5D returns. Discover more about the Trefis RV strategy that has outperformed its all-cap stocks benchmark (a blend of the S&P 500, S&P mid-cap, and Russell 2000), delivering strong results for investors. Additionally, if you seek upside with a smoother experience than an individual stock like Hims & Hers Health, consider the High Quality portfolio, which has surpassed the S&P and yielded >91% returns since its inception.
Yahoo
39 minutes ago
- Yahoo
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025
Conference Call and Webcast at 8:30 AM Eastern Time NEW YORK, July 30, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it will host a business update conference call and webcast on Wednesday, August 13, 2025, at 8:30 AM ET. During the call, Lishan Aklog, M.D., Lucid's Chairman and Chief Executive Officer, will provide a business update, including an overview of the Company's operations and continued growth strategy. In addition, Dennis McGrath, Lucid's Chief Financial Officer, will discuss the Company's second quarter 2025 financial results. The webcast will be available at the investor relations section of the Company's website at Alternatively, to access the conference call by telephone, U.S.-based callers should dial 1-800-836-8184 and international listeners should dial 1-646-357-8785. All listeners should provide the operator with the conference call name "Lucid Diagnostics Business Update" to join. Following the conclusion of the conference call, a replay will be available for 30 days on the investor relations section of the Company's website at About Lucid DiagnosticsLucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM). Lucid is focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, who are at risk of developing esophageal precancer and cancer. Lucid's EsoGuard® Esophageal DNA Test, performed on samples collected in a brief, noninvasive office procedure with its EsoCheck® Esophageal Cell Collection Device, represent the first and only commercially available tools designed with the goal of preventing cancer and cancer deaths through widespread, early detection of esophageal precancer in at-risk patients. For more information, please visit and for more information about its parent company PAVmed, please visit View original content to download multimedia: SOURCE Lucid Diagnostics Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
